Emergent BioSolutions Inc. — Institutional Ownership
Which tracked institutions hold EBS, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
25
Funds holding
$106803282
Total value held
Buying
17 added/new · 8 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $39525100 | 4716599 | +375137 | +8.64% |
| 2 | State Street Corp | $24556367 | 2929238 | +79537 | +2.79% |
| 3 | Goldman Sachs Group Inc | $8676828 | 1035421 | +223861 | +27.58% |
| 4 | Federated Hermes, Inc. | $6964828 | 831125 | +831125 | NEW BUY |
| 5 | Prudential Financial Inc | $6753400 | 805895 | +357080 | +79.56% |
| 6 | Northern Trust Corp | $5207944 | 621473 | +20561 | +3.42% |
| 7 | Morgan Stanley | $3936225 | 469715 | -274821 | -36.91% |
| 8 | Ubs Group Ag | $3067172 | 366011 | +366011 | NEW BUY |
| 9 | Bank Of New York Mellon Corp | $1840760 | 219661 | +4618 | +2.15% |
| 10 | Franklin Resources Inc | $1398144 | 166843 | +4900 | +3.03% |
| 11 | Bank Of America Corp /De/ | $1275596 | 152219 | -31224 | -17.02% |
| 12 | Invesco Ltd. | $1224024 | 146065 | +146065 | NEW BUY |
| 13 | Citigroup Inc | $552409 | 65920 | +54679 | +486.42% |
| 14 | Wells Fargo & Company/Mn | $422268 | 50390 | +20527 | +68.74% |
| 15 | Truist Financial Corp | $365966 | 43671 | -30362 | -41.01% |
| 16 | Bank Of Montreal /Can/ | $229847 | 27428 | -4 | -0.01% |
| 17 | Jpmorgan Chase & Co | $207042 | 24473 | +2932 | +13.61% |
| 18 | Royal Bank Of Canada | $204000 | 24341 | +23274 | +2181.26% |
| 19 | Stifel Financial Corp | $169569 | 20235 | +20235 | NEW BUY |
| 20 | Sei Investments Co | $138745 | 16557 | -2654 | -13.82% |
| 21 | Barclays Plc | $64106 | 7650 | -3552 | -31.71% |
| 22 | Us Bancorp \De\ | $14556 | 1737 | -239 | -12.10% |
| 23 | Fifth Third Bancorp | $5187 | 619 | +415 | +203.43% |
| 24 | Pnc Financial Services Group, Inc. | $2312 | 276 | -5 | -1.78% |
| 25 | Amalgamated Financial Corp. | $887 | 21600 | +21600 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.